Faculty Information - Anraku Makoto

Anraku Makoto

Department / Course FACULTY OF PHARMACEUTICAL SCIENCES Department of Pharmaceutical Sciences

Job

Academic conference presentation
1.	2022/07	The preparation and validation of chitosan tablets that rapidly disperse and disintegrate as an oral adsorbent in the treatment of lifestyle-related diseases (APA BIOFORUM-2022)
2.	2019/10	Hydrophobically Modified Hydroxypropylmethyl Cellulose/Cyclodextrin Thermoresponsive Hydrogels for Use in Drug Delivery (The Asian Federation for Pharmaceutical Sciences Conference 2019)
3.	2019/10	Administration of Macromolecular Sacran Suppresses Renal Injury and Oxidative Stress in Chronic Renal Failure Model Rats (The Asian Federation for Pharmaceutical Sciences Conference 2019)
4.	2019/10	Biomedical Application of Surface-Deacetylated Chitin Nanofibers on Oxidative Stress Related Diseases (The Asian Federation for Pharmaceutical Sciences Conference 2019)
5.	2019/09	Clinical application of surface-deacetylated chitin nanofibers on oxidative stress related diseases (The Workshop on Chitin Biology and Beyond)
6.	2019/09	Evaluation of a surface deacetylated chitin nanofiber sponge containing antifungal medicine (The Workshop on Chitin Biology and Beyond)
7.	2019/09	Preparation of granulated chitosan and its in-vitro and in-vivo disintegration ability (The Workshop on Chitin Biology and Beyond)
8.	2018/10	An Oral Absorbent, Surface-Deacetylated Chitin Nano-Fiber Ameliorates Renal Injury and Oxidative Stress in 5/6 Nephrectomized Rats (The American Society of Nephrology (ASN)/KidneyWeek)
9.	2018/10	An Oral Absorbent, Surface-Deacetylated Chitin Nano-Fiber Ameliorates Renal Injury and Oxidative Stress in 5/6 Nephrectomized Rats (The American Society of Nephrology (ASN)/KidneyWeek)
10.	2018/09	Clinical Applications of Chitosan and Surface-deacetylated Chitin Nanofibers on Oxidativce Stress Related Diseases（1st Place Award） (24th Conference of Polish Chitin Society)
11.	2018/08	Clinical application of chitosan and chitosan-nanofibers in the treatment of oxidative stress related diseases (14th International Chitin and Chitosan Conference)
12.	2018/08	Preparation and evaluation of sacran / chitosan nanofiber complex for drug sustained-release patch (14th International Chitin and Chitosan Conference)
13.	2018/08	Slow-release of olmesartan from tablets containing chitosan/sulfobutyl ether β-cyclodextrin composites (14th International Chitin and Chitosan Conference)
14.	2018/04	Preparation of thermoresponsive sangelose®/cyclodextrin injectable gel for a sustained release system of proteins (19th International Cyclodextrin Symposium)
15.	2017/12	Surface-deacetylated Chitin Nanofibers Reinforced with a Sulfobutyl Ether b-cyclodextrin gel loaded with Prednisolone as Potential Therapy for Inflammatory Bowel Disease (9th Asian Cyclodextrin Conference)
16.	2017/05	Preparation of Highly Dispersible C60 Nanoparticles by Sugammadex, An Anionic γ-Cyclodextrin Derivative for the Photodynamic Therapy (6th FIP Pharamceutical Sciences World Congress)
17.	2016	Pleiotropic Effects of Chitosan and Chitosan-nanofibers on Oxidative Stress Related Diseases (International Conference on Small Science 2016)
18.	2015	Formation of Elastic Gels from Deacetylated Chitin Nanofibers Reinforced with Sulfobutyl Ether β-Cyclodextrin (7th Iberoamerican Chitin Symposium)
19.	2015	Effects of chitosan on oxidative stress and related factors in chronic renal failure (12th International Conference of the European Chitin Society 13th International Conference on Chitin and Chitosan)
20.	2013	Effects of chitosan on oxidative stress and hyperphosphatemia in hemodialysis patients (International Conference of the European Chitin Society)
21.	2011	Quantitative Analysis of Cysteine-34 on the Anitioxidative Properties of Human Serum Albumin and its Physiological Significance in Hemodialysis Patients (Helsinki Drug Research 2011 Congress)
22.	2009	Antioxidant property of several molecular weight chitosans in in vitro and in vivo studies (The Asian Federation for Pharmaceutical Sciences)
23.	2009	Antioxidant protection of plasma protein by different molecular weight chitosans in in vitro and in vivo studies (The 5th Joint Meeting of The Societies For Free Radical Research Australasia and Japan)
24.	2007	An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure (PSWC 2007 - 3rd Pharmaceutical Sciences World Congress)
25.	2007	Effect of low molecular weight chitosan supplement on oxidative stress in normal subjects (The 4th Joint Meeting of the Society for Free Radical Research Australasia and Japan)
26.	2006	Oxidation and Carboxyl Methyl Lysine (CML)-Modification of Albumin; Possible Involvement in the Progression of Oxidative Stress in Hemodialysis Patients (1st Asia Pacific ISSX Meeting)
27.	2005	Biological Influence of Human Serum Albumin (HSA) Oxidation in Hemodialysis (HD) Patients (13th NA ISSX Meeting/20th JSSX Meeting)